Nasdaq:OBSV
#ObsEva #Announces #Progress #Cost #Reduction #Initiatives Transition of linzagolix program to Kissei Pharmaceutical Co., Ltd. substantially complete with approximately $16.0 million savings expected from...
Hi, what are you looking for?
#ObsEva #Announces #Progress #Cost #Reduction #Initiatives Transition of linzagolix program to Kissei Pharmaceutical Co., Ltd. substantially complete with approximately $16.0 million savings expected from...
#ObsEva #Announces #IND #Approval #Yuyuan #Biosciences #Phase Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland –...